ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 30 filers reported holding ACHILLES THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,052 | -3.8% | 2,255,375 | 0.0% | 0.09% | +33.3% |
| Q2 2023 | $2,132 | -1.3% | 2,255,375 | 0.0% | 0.07% | -48.4% |
| Q1 2023 | $2,160 | +6.4% | 2,255,375 | 0.0% | 0.13% | +13.3% |
| Q4 2022 | $2,030 | -100.0% | 2,255,375 | 0.0% | 0.11% | -48.2% |
| Q3 2022 | $5,097,000 | -10.3% | 2,255,375 | 0.0% | 0.22% | -28.3% |
| Q2 2022 | $5,684,000 | -14.3% | 2,255,375 | 0.0% | 0.30% | +9.4% |
| Q1 2022 | $6,631,000 | -41.3% | 2,255,375 | 0.0% | 0.28% | -9.4% |
| Q4 2021 | $11,299,000 | -35.7% | 2,255,375 | 0.0% | 0.31% | -21.9% |
| Q3 2021 | $17,569,000 | -20.4% | 2,255,375 | 0.0% | 0.39% | -12.3% |
| Q2 2021 | $22,080,000 | -40.8% | 2,255,375 | 0.0% | 0.45% | -32.1% |
| Q1 2021 | $37,326,000 | – | 2,255,375 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 11,086,909 | $10,087,979 | 15.03% |
| Artal Group S.A. | 2,255,375 | $2,052 | 0.09% |
| Redmile Group, LLC | 1,608,089 | $1,463,200 | 0.07% |
| Forefront Analytics, LLC | 78,169 | $71,126 | 0.04% |
| Baker Brothers Advisors | 2,557,149 | $2,326,750 | 0.01% |
| Point72 Asset Management, L.P. | 1,413,809 | $1,286,425 | 0.00% |
| XTX Topco Ltd | 21,084 | $19,184 | 0.00% |
| Coppell Advisory Solutions LLC | 1,000 | $5,560 | 0.00% |
| Renaissance Technologies | 437,528 | $398 | 0.00% |
| JPMORGAN CHASE & CO | 989 | $900 | 0.00% |